Peregrine Capital Management LLC Moderna, Inc. Transaction History

Peregrine Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$118.5 - $160.53 $54,510 - $73,843	460 Added 19.58%	2,809 $341,000
Q1 2023 Apr 26, 2023	SELL	$135.66 - $197.02 $102,965 - $149,538	-759 Reduced 24.42%	2,349 $360,000
Q4 2022 Jan 10, 2023	BUY	$118.38 - $210.04 $367,925 - $652,804	3,108 New	3,108 $558,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.